| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 03/06/2001 | US6197791 N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 03/01/2001 | WO2001015175A2 Process for recycling ionic liquids |
| 03/01/2001 | WO2001014371A1 N-heterocyclic derivatives as nos inhibitors |
| 03/01/2001 | WO2001014355A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments |
| 03/01/2001 | WO2001014348A1 Formation of heterocycles |
| 03/01/2001 | WO2001014341A1 Agents for controlling animal diseases caused by parasites |
| 03/01/2001 | WO2001014338A1 NOVEL INTEGRIN αVβ3 INHIBITORS |
| 03/01/2001 | WO2001014337A1 αvβ3 INTEGRIN INHIBITORS |
| 03/01/2001 | DE19939981A1 Neue Inhibitoren des Integrins alphavß3 New inhibitors of integrin alphavß3 |
| 03/01/2001 | DE19939980A1 Inhibitoren des Integrins alphavbeta¶3¶ Inhibitors of integrin alphavbeta¶3¶ |
| 03/01/2001 | CA2382850A1 Novel inhibitors of the integrin .alpha.v.beta.3 |
| 03/01/2001 | CA2382561A1 Inhibitors of integrin .alpha.v.beta.3 |
| 03/01/2001 | CA2382311A1 Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 02/28/2001 | EP1077994A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 02/28/2001 | EP1077949A2 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer |
| 02/28/2001 | EP1077931A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/28/2001 | EP1077929A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | CN1285824A Process for the production of formylimidazoles |
| 02/28/2001 | CN1285823A Phenyl-alkyl-imidazoles as H3 receptor antagonists |
| 02/28/2001 | CN1285822A H receptor ligands of phenyl-alkyl-imidazoles type |
| 02/28/2001 | CA2317097A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/28/2001 | CA2317001A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/28/2001 | CA2316748A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/27/2001 | US6194451 Prevent release tumor necrosis factor; antiinflammatory agents |
| 02/27/2001 | US6194448 N, N-disubstituted amides that inhibit the binding of integrins to their receptors |
| 02/27/2001 | US6194438 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one, and compositions and methods for inhibiting abnormal cell growth comprising said derivatives |
| 02/27/2001 | US6194425 Viricides, antitumor agents |
| 02/27/2001 | US6194380 Agents for promoting bone formation |
| 02/27/2001 | US6194184 Comprising the reaction product of a compound having at least one histidine group such as an antibody, enzyme, or nucleic acid, and potassium tetrathiocyanatopalladate (ii); for use in assays |
| 02/27/2001 | US6194132 Photographic element, compound, and process |
| 02/27/2001 | CA2316529A1 Manufacture of a cyclic acid |
| 02/27/2001 | CA2101316C Gnrh analogs |
| 02/22/2001 | WO2001012615A2 Fungicidal heteroaryl hepta-2,6-dienoic acid derivatives |
| 02/22/2001 | WO2001012594A1 Processes for the preparation of aromatic sulfenyl chlorides and so forth |
| 02/22/2001 | WO2001012593A1 Arylsulfonanilide derivatives |
| 02/22/2001 | WO2001012575A1 Methods for preparing perfluorinated [18f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection |
| 02/22/2001 | WO2000078724A3 Imidazolinderivatives their preparation and their pharmaceutical use |
| 02/22/2001 | WO2000055126A3 N-cyanomethylamides as protease inhibitors |
| 02/22/2001 | WO2000039716A3 Arylpropenylimidazoles as farnesyl-protein transferase inhibitors |
| 02/22/2001 | DE19939516A1 New 1-carboxyalkyl-4-(hetero)aryl-piperazine derivatives, as microsomal triglyceride transfer protein inhibitors useful for reducing plasma atherogenic lipoprotein levels, e.g. in treatment of hyperlipidemia |
| 02/22/2001 | CA2378712A1 Methods for preparing perfluorinated [18f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection |
| 02/21/2001 | EP1076718A1 Novel method for preparing synthesis intermediates |
| 02/21/2001 | EP1076663A1 Functionalized alkyl and alkenyl side chain derivatives of glycinamides as farnesyl transferase inhibitors |
| 02/21/2001 | EP1076651A1 Substituted sulphonyl cyanamides, method for producing same and their use as medicament |
| 02/21/2001 | EP1076644A1 N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 02/21/2001 | CN1284957A Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 02/21/2001 | CN1284950A Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists |
| 02/21/2001 | CN1284949A Cyclic alkyleneureas containing monomers and polymers and latices therefrom |
| 02/20/2001 | US6191282 Derivatives of 5-membered nitrogen containing heterocyclic ring is used as anticarcinogenic agent and anticoagulant |
| 02/20/2001 | US6191171 Para-aminomethylaryl carboxamide derivatives |
| 02/20/2001 | US6191157 Anticholesterol agents; cardiovascular disorders |
| 02/20/2001 | US6190850 Photographic element, compound, and process |
| 02/15/2001 | WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | WO2001010841A2 Fluorene derivatives as integrin inhibitors |
| 02/15/2001 | WO2001010827A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 02/15/2001 | WO2001010823A1 Carboxylic acid amides, their production and their use as drugs |
| 02/15/2001 | WO2001010799A1 Methods for preparing n-[(aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
| 02/15/2001 | CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | CA2380981A1 Fluorene derivatives |
| 02/15/2001 | CA2378310A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 02/14/2001 | CN1284066A Substituted inidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors |
| 02/14/2001 | CN1284060A Novel metalloproteinase inhibitors |
| 02/14/2001 | CN1284057A Adamantane derivatives |
| 02/14/2001 | CN1284055A Derivatives of 2,2-dimethyl 3-(2-fluoro vinyl) cyclopropane carboxylic acid, their prepn process and use as pesticides |
| 02/13/2001 | US6187944 A phenyl acrylonitrile compounds useful as active ingredients of an insecticide, a miticide, a nematicide, a soil pesticide, a fungicide and a marine antifouling agent |
| 02/13/2001 | US6187928 Treating fungal diseases |
| 02/13/2001 | US6187924 Inhibitors of matrix metalloproteinases and/or tumor necrosis factor-alpha-mediated diseases |
| 02/13/2001 | US6187812 For controlling animal pests or harmful fungi; (e,e,e)-2-methoxyimino-2-(2'-(1?-methyl, 1?-(1?'-ethoxyiminoethyl))iminooxymethyl)phenylacetic acid monomethylamide, for example |
| 02/08/2001 | WO2001009128A1 Thiourea and isothiourea derivatives for inhibiting ras-transformed cell growth |
| 02/08/2001 | WO2001009127A1 Benzoxazine derivatives and their therapeutic use |
| 02/08/2001 | WO2001009120A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 02/08/2001 | WO2001009117A1 Tricyclic compounds as glycine transport inhibitors |
| 02/08/2001 | WO2001009103A2 Imidazole antiproliferative agents |
| 02/08/2001 | WO2001009096A2 Potassium channel openers |
| 02/08/2001 | WO2001009095A1 Mutilin derivatives and their use as antibacterials |
| 02/08/2001 | WO2001009090A2 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 02/08/2001 | WO2001009088A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 02/08/2001 | DE19937394A1 Fluorenderivate Fluoro derivatives |
| 02/08/2001 | CA2380371A1 Thiourea and isothiourea derivatives for inhibiting ras-transformed cell growth |
| 02/08/2001 | CA2380032A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 02/08/2001 | CA2378942A1 Imidazole antiproliferative agents |
| 02/08/2001 | CA2378936A1 Potassium channel openers |
| 02/07/2001 | EP1075005A2 Electrolyte composition, and photo-electro-chemical cell |
| 02/07/2001 | EP1073650A1 Guanidine derivatives |
| 02/07/2001 | EP1073640A1 Naphthalene derivatives, their production and use |
| 02/07/2001 | EP1073638A1 Heterocyclically substituted amides, their production and their use |
| 02/07/2001 | EP1073633A2 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 02/07/2001 | EP1073626A1 Azine used as fungicides |
| 02/07/2001 | CN1283183A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 02/07/2001 | CN1283181A Substituted beta-alanines |
| 02/06/2001 | US6184389 Feature a plurality of functional groups attached to backbone and phosphoramidate sites |
| 02/06/2001 | US6184361 Rhenium and technetium complexes containing a hypoxia-localizing moiety |
| 02/06/2001 | US6184249 Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes |
| 02/06/2001 | US6184242 2-(substituted-phenyl)amino-imidazoline derivatives |
| 02/06/2001 | US6184241 Aspartic protease inhibitors |
| 02/06/2001 | US6184227 Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
| 02/06/2001 | US6184216 Effective both as antidiabetic agent and antiobesity agent |
| 02/06/2001 | US6184210 Dipeptide-based caspase (proteolytic family of cysteine proteases whose active site cysteine residue is essential for ice-mediated apoptosis) inhibitors of given formula are potent inhibitors of apoptosis |